Literature DB >> 10913175

Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface.

G Jiang1, J den Hertog, T Hunter.   

Abstract

We reported previously that the N-terminal D1 catalytic domain of receptor protein-tyrosine phosphatase alpha (RPTPalpha) forms a symmetrical, inhibited dimer in a crystal structure, in which a helix-turn-helix wedge element from one monomer is inserted into the catalytic cleft of the other monomer. Previous functional studies also suggested that dimerization inhibits the biological activity of a CD45 chimeric RPTP and the catalytic activity of an isolated RPTPsigma D1 catalytic domain. Most recently, we have also shown that enforced dimerization inhibits the biological activity of full-length RPTPalpha in a wedge-dependent manner. The physiological significance of such inhibition is unknown, due to a lack of understanding of how RPTPalpha dimerization is regulated in vivo. In this study, we show that transiently expressed cell surface RPTPalpha exists predominantly as homodimers, suggesting that dimerization-mediated inhibition of RPTPalpha biological activity is likely to be physiologically relevant. Consistent with our published and unpublished crystallographic data, we show that mutations in the wedge region of D1 catalytic domain and deletion of the entire D2 catalytic domain independently reduced but did not abolish RPTPalpha homodimerization, suggesting that both domains are critically involved but that neither is essential for homodimerization. Finally, we also provide evidence that both the RPTPalpha extracellular domain and the transmembrane domain were independently able to homodimerize. These results lead us to propose a zipper model in which inactive RPTPalpha dimers are stabilized by multiple, relatively weak dimerization interfaces. Dimerization in this manner would provide a potential mechanism for negative regulation of RPTPalpha. Such RPTPalpha dimers could be activated by extracellular ligands or intracellular binding proteins that induce monomerization or by intracellular signaling events that induce an open conformation of the dimer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913175      PMCID: PMC86069          DOI: 10.1128/MCB.20.16.5917-5929.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

1.  Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta.

Authors:  K Meng; A Rodriguez-Peña; T Dimitrov; W Chen; M Yamin; M Noda; T F Deuel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

2.  A versatile in vivo and in vitro eukaryotic expression vector for protein engineering.

Authors:  S Green; I Issemann; E Sheer
Journal:  Nucleic Acids Res       Date:  1988-01-11       Impact factor: 16.971

3.  Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors.

Authors:  J D Haley; J J Hsuan; M D Waterfield
Journal:  Oncogene       Date:  1989-03       Impact factor: 9.867

4.  A genetic system for analysis of staphylococcal nuclease.

Authors:  D Shortle
Journal:  Gene       Date:  1983 May-Jun       Impact factor: 3.688

5.  Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn.

Authors:  S Ponniah; D Z Wang; K L Lim; C J Pallen
Journal:  Curr Biol       Date:  1999-05-20       Impact factor: 10.834

6.  Identification of p130cas as an in vivo substrate of receptor protein-tyrosine phosphatase alpha.

Authors:  A Buist; C Blanchetot; L G Tertoolen; J den Hertog
Journal:  J Biol Chem       Date:  2000-07-07       Impact factor: 5.157

7.  A phosphotyrosine displacement mechanism for activation of Src by PTPalpha.

Authors:  X M Zheng; R J Resnick; D Shalloway
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

8.  Increased mRNA expression of the receptor-like protein tyrosine phosphatase alpha in late stage colon carcinomas.

Authors:  K Tabiti; D R Smith; H S Goh; C J Pallen
Journal:  Cancer Lett       Date:  1995-07-13       Impact factor: 8.679

9.  Truncation of the human EGF receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts.

Authors:  K Khazaie; T J Dull; T Graf; J Schlessinger; A Ullrich; H Beug; B Vennström
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

10.  The LAR transmembrane protein tyrosine phosphatase and a coiled-coil LAR-interacting protein co-localize at focal adhesions.

Authors:  C Serra-Pagès; N L Kedersha; L Fazikas; Q Medley; A Debant; M Streuli
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

View more
  40 in total

1.  Two mechanisms activate PTPalpha during mitosis.

Authors:  X M Zheng; D Shalloway
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

Review 2.  Pulling strings below the surface: hormone receptor signaling through inhibition of protein tyrosine phosphatases.

Authors:  X Espanel; S Wälchli; R P Gobert; M El Alama; M L Curchod; N Gullu-Isler; R Hooft van Huijsduijnen
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

3.  Dimerization in vivo and inhibition of the nonreceptor form of protein tyrosine phosphatase epsilon.

Authors:  Hila Toledano-Katchalski; Zohar Tiran; Tal Sines; Gidi Shani; Shira Granot-Attas; Jeroen den Hertog; Ari Elson
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

4.  Oxidative stress-induced oligomerization inhibits the activity of the non-receptor tyrosine phosphatase STEP61.

Authors:  Ishani Deb; Ranjana Poddar; Surojit Paul
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

5.  Integrin CD11a cytoplasmic tail interacts with the CD45 membrane-proximal protein tyrosine phosphatase domain 1.

Authors:  Xin Geng; Ren-Hong Tang; S K Alex Law; Suet-Mien Tan
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

6.  The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1.

Authors:  Jeyanthy Eswaran; Judit E Debreczeni; Emma Longman; Alastair J Barr; Stefan Knapp
Journal:  Protein Sci       Date:  2006-05-02       Impact factor: 6.725

7.  Liprin-alpha has LAR-independent functions in R7 photoreceptor axon targeting.

Authors:  Kerstin Hofmeyer; Corinne Maurel-Zaffran; Helen Sink; Jessica E Treisman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-24       Impact factor: 11.205

Review 8.  CD45: all is not yet crystal clear.

Authors:  Nick Holmes
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

9.  Low-resolution structure and fluorescence anisotropy analysis of protein tyrosine phosphatase eta catalytic domain.

Authors:  Huita C Matozo; Maria A M Santos; Mario de Oliveira Neto; Lucas Bleicher; Luís Mauricio T R Lima; Rodolfo Iuliano; Alfredo Fusco; Igor Polikarpov
Journal:  Biophys J       Date:  2007-03-30       Impact factor: 4.033

10.  Functions of the ectodomain and cytoplasmic tyrosine phosphatase domains of receptor protein tyrosine phosphatase Dlar in vivo.

Authors:  Neil X Krueger; R Sreekantha Reddy; Karl Johnson; Jack Bateman; Nancy Kaufmann; Daniella Scalice; David Van Vactor; Haruo Saito
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.